Maxwell Biosciences is a preclinical-stage company developing the CLAROMER biotechnology platform. This innovative platform creates low-molecular-weight compounds that mimic peptides and penetrate membranes easily, offering potential treatments for previously untreatable conditions.
Patient-centered, proactive medicine that maximizes the pursuit of your dreams through innovative diagnostics and technologies.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.